FDA's Bone, Reproductive, and Urologic Drugs Advisory Committee to Hold Meeting

Summary

The FDA's Bone, Reproductive, and Urologic Drugs Advisory Committee will convene for a meeting to discuss various topics related to bone, reproductive, and urologic drugs, as announced by the U.S. Food and Drug Administration (FDA).